EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease

Sriram Balusu iD, Bart De Strooper iD

Acta Neuropathologica · 2024-06 · 147 (1)

DOI: 10.1007/s00401-024-02747-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Neuropathologica, online erschienen am 09.06.2024. Verfasst von Sriram Balusu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for the Research of Neurodegenerative Diseases, VIB Center for Brain and Disease Research, 3000, Leuven, Belgium. sriram.balusu@kuleuven.b…. Hauptthemen laut MEDLINE: Necroptosis, Alzheimer Disease. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Fonds Wetenschappelijk Onderzoek, MEDICAL RESEARCH COUNSIL.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although apoptosis, pyroptosis, and ferroptosis have been implicated in AD, none fully explains the extensive neuronal loss observed in AD brains. Recent evidence shows that necroptosis is abundant in AD, that necroptosis is closely linked to the appearance of Tau pathology, and that necroptosis markers accumulate in granulovacuolar neurodegeneration vesicles (GVD). We review here the neuron-specific activation of the granulovacuolar mediated neuronal-necroptosis pathway, the potential AD-relevant triggers upstream of this pathway, and the interaction of the necrosome with the endo-lysosomal pathway, possibly providing links to Tau pathology. In addition, we underscore the therapeutic potential of inhibiting necroptosis in neurodegenerative diseases such as AD, as this presents a novel avenue for drug development targeting neuronal loss to preserve cognitive abilities. Such an approach seems particularly relevant when combined with amyloid-lowering drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NecroptosisAlzheimer DiseaseHumansAnimalsNeuronsNerve Degeneration

Autor:innen und Institutionen

  • Laboratory for the Research of Neurodegenerative Diseases, VIB Center for Brain and Disease Research, 3000, Leuven, Belgium. sriram.balusu@kuleuven.be.
  • Leuven Brain Institute, KU Leuven, 3000, Leuven, Belgium. sriram.balusu@kuleuven.be.
  • Laboratory for the Research of Neurodegenerative Diseases, VIB Center for Brain and Disease Research, 3000, Leuven, Belgium. b.strooper@ukdri.ucl.ac.uk.
  • Leuven Brain Institute, KU Leuven, 3000, Leuven, Belgium. b.strooper@ukdri.ucl.ac.uk.
  • UK Dementia Research Institute at UCL, London, WC1E 6BT, UK. b.strooper@ukdri.ucl.ac.uk.

ORCID-Profile: Sriram Balusu, Bart De Strooper

Förderung

  • European Research Council
  • Fonds Wetenschappelijk Onderzoek
  • MEDICAL RESEARCH COUNSIL
  • Stichting Wetenschappelijk Onderzoek Oogziekenhuis
  • Vlaams Instituut voor Biotechnologie
  • Cure Alzheimer's Fund
  • Methusalem grant

Zitieren

APA

Balusu, S., & De Strooper, B. (2024). The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease. Acta Neuropathologica, 147(1). https://doi.org/10.1007/s00401-024-02747-5

Vancouver

Balusu S, De Strooper B. The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease. Acta Neuropathologica. 2024;147(1). doi:10.1007/s00401-024-02747-5

BibTeX
@article{Balusu2024,
  author = {Balusu, Sriram and De Strooper, Bart},
  title = {The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease},
  journal = {Acta Neuropathologica},
  year = {2024},
  volume = {147},
  number = {1},
  doi = {10.1007/s00401-024-02747-5}
}
Kostenlos starten →